Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/1996
03/26/1996US5501954 Method of detecting cellular material
03/26/1996US5501853 Peptide plasminogen activators
03/21/1996WO1996008582A2 Specific and universal probes and amplification primers to rapidly detect and identify common bacterial pathogens and antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories
03/21/1996WO1996008580A1 In vitro method for predicting the evolutionary response of hiv protease to a drug targeted thereagainst
03/21/1996WO1996008574A1 Novel implant and novel vector for the treatment of acquired diseases
03/21/1996WO1996008573A1 Phytopathogenic dna virus resistant transgenic plants and seeds and methods for obtaining same
03/21/1996WO1996008572A1 Method for the production of recombinant proteins, plasmids and modified cells
03/21/1996WO1996008571A1 Identification of dna-damaging substances by means of cell lines capable of overexpressing poly(adp-ribose)-polymerase
03/21/1996WO1996008570A1 Expression and export technology of proteins as immunofusins
03/21/1996WO1996008569A2 Methods and compositions for identifying streptococcus containing a cysteine protease or fragment thereof
03/21/1996WO1996008568A2 CLONING AND EXPRESSION OF cDNA FOR HUMAN DIHYDROPYRIMIDINE DEHYDROGENASE
03/21/1996WO1996008567A1 Microorganisms and methods for overproduction of dahp by cloned pps gene
03/21/1996WO1996008566A2 Process for producing polyhydroxylic fatty acids and recombinant bacterial strains for carrying out the process
03/21/1996WO1996008565A2 RECOMBINANT PEPTIDES DERIVED FROM THE Mc3 ANTI-BA46 ANTIBODY, METHODS OF USE THEREOF, AND METHODS OF HUMANIZING ANTIBODY PEPTIDES
03/21/1996WO1996008564A1 Humanised antibody to integrin chain beta-1
03/21/1996WO1996008563A1 Process for manufacture of a modified collagen-induced platelet aggregation inhibitor pallidipin
03/21/1996WO1996008562A1 Biologically active molecules derived from neurotrophins
03/21/1996WO1996008561A1 Method for detection of malfolded protein
03/21/1996WO1996008560A1 Transduction of genes into human hematopoietic stem cells using recombinant adeno-associated viral vectors
03/21/1996WO1996008559A1 Glycosaminoglycan-degrading enzyme inhibition and resultant disease therapies
03/21/1996WO1996008558A1 Modulation of drug radiation resistant genes
03/21/1996WO1996008557A1 Human inositol monophosphatase h1
03/21/1996WO1996008515A1 Anti-receptor and growth blocking agents to the vitamin b12/transcobalamin ii receptor and binding sites
03/21/1996WO1996008514A1 Monoclonal antibodies against human colon carcinoma-associated antigens and uses therefor
03/21/1996WO1996008513A1 Cytotactin derivatives that stimulate attachment and neurite outgrowth, and methods of making and using same
03/21/1996WO1996008512A1 POLYPEPTIDES WITH Fc BINDING ABILITY
03/21/1996WO1996008511A1 ACTIVE INDUCTION OR PASSIVE IMMUNIZATION OF ANTI-gp48 ANTIBODIES AND ISOLATED gp48 PROTEIN
03/21/1996WO1996008510A1 Hu-B1.219, A NOVEL HUMAN HEMATOPOIETIN RECEPTOR
03/21/1996WO1996008506A1 Phosphorus-32 labeling of antibodies for cancer therapy
03/21/1996WO1996008504A1 Zwittermicin resistance gene and biocontrol bacteria with the gene
03/21/1996WO1996008500A1 Process and device for isolating cellular substances such as nucleic acids from natural sources
03/21/1996WO1996008275A1 Secretory leukocyte protease inhibitor as an inhibitor of tryptase
03/21/1996WO1996008274A2 Conjugates of heparin-binding epidermal growth factor-like growth factor with targeted agents
03/21/1996WO1996008272A1 Use of antibodies to block the effects of gram-positive bacteria and mycobacteria
03/21/1996WO1996008269A1 Inhibition of human rotavirus infection
03/21/1996WO1996008268A1 Inhibition of endothelin-1 to reduce inflammatory processes
03/21/1996WO1996008263A1 Intracellular delivery of chemical agents to a specific cell type
03/21/1996WO1996008136A1 Pest trap plants and crop protection
03/21/1996WO1996005309A3 Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
03/21/1996WO1996004382A3 Secreted viral proteins useful for vaccines and diagnostics
03/21/1996WO1996004373A3 Recombinant production of biologically active peptides and proteins
03/21/1996WO1995034679A3 Defects in drug metabolism
03/21/1996WO1995032290A3 Non-a/non-b/non-c/non-d/non-e hepatitis agents and molecular cloning thereof
03/21/1996WO1995030757A3 Metalloproteases from fusarium and aspergillus having thermolysin-like activity
03/21/1996WO1995020039A3 Customized proteases with altered transacylation activity
03/21/1996EP0711200A4 Microfabricated reactor
03/21/1996DE4435485C1 Verfahren zur Gewinnung von hochreinem von Willebrand-Faktor Process for the recovery of high purity von Willebrand factor
03/21/1996DE4433307A1 Ein isoliertes Nuckleinsäurefragment und daraus abgeleitete Produkte An isolated Nuckleinsäurefragment and derived products
03/21/1996DE4433134A1 Verfahren zur Herstellung von Polyhydroxyfettsäuren sowie rekombinanter Bakterienstämme zur Durchführung des Verfahrens Process for the preparation of polyhydroxy fatty acids and recombinant bacterial strains for carrying out the method
03/21/1996DE4433130A1 Identifizierung von DNA-schädigenden Substanzen durch Poly(ADP-Ribose)-Polymerase überexprimierende Zellinien Identification of DNA-damaging substances by poly (ADP-ribose) polymerase-overexpressing cell lines
03/21/1996DE4432654A1 Verfahren und Vorrichtung zur Isolierung von Zellinhaltsstoffen wie Nukleinsäuren aus natürlichen Quellen Method and apparatus for isolating cell ingredients, such as nucleic acids from natural sources
03/21/1996CA2219915A1 Pest trap plants and crop protection
03/21/1996CA2203264A1 Process for producing polyhydroxylic fatty acids and recombinant bacterial strains for carrying out the process
03/21/1996CA2200097A1 Recombinant peptides derived from the mc3 anti-ba46 antibody, methods of use thereof, and methods of humanizing antibody peptides
03/21/1996CA2200088A1 Phosphorus-32 labeling of antibodies for cancer therapy
03/21/1996CA2200087A1 Active induction or passive immunization of anti-gp48 antibodies and isolated gp48 protein
03/21/1996CA2199939A1 Inhibition of endothelin-1 to reduce inflammatory processes
03/21/1996CA2199867A1 Methods and compositions for identifying streptococcus containing a cysteine protease or fragment thereof
03/21/1996CA2199820A1 Modulation of drug radiation resistant genes
03/21/1996CA2199808A1 Cloning and expression of cdna for human dihydropyrimidine dehydrogenase
03/21/1996CA2199805A1 In vitro method for predicting the evolutionary response of hiv protease to a drug targeted thereagainst
03/21/1996CA2199749A1 Humanised antibody to integrin chain beta-1
03/21/1996CA2199746A1 Secretory leukocyte protease inhibitor as an inhibitor of tryptase
03/21/1996CA2199740A1 Monoclonal antibodies against human colon carcinoma-associated antigens and uses therefor
03/21/1996CA2199719A1 Process for manufacture of a modified collagen-induced platelet aggregation inhibitor pallidipin
03/21/1996CA2199707A1 Inhibition of human rotavirus infection
03/21/1996CA2198361A1 Intracellular delivery of chemical agents to a specific cell type
03/21/1996CA2198263A1 Method for detection of malfolded protein
03/21/1996CA2198248A1 Polypeptides with fc binding ability
03/20/1996EP0702090A2 Coamplification of target nucleic acids using volume exclusion agent, in reaction composition, test kit and test device useful therefor
03/20/1996EP0702085A1 Recombinant infectious non-segmented negative strand RNA virus
03/20/1996EP0702084A1 Recombinant retroviruses
03/20/1996EP0702083A2 Polypeptides and fusion proteins that contain the UL57 open reading frame or the C-terminus of tegument protein pp150 from HCMV, corresponding oligonucleotides and diagnostic test kits
03/20/1996EP0702082A1 Amino acid sequences of anti-idiotypic antibodies against anti-cancer human monoclonal antibody, and dna base sequences encoding those sequences
03/20/1996EP0701818A2 Therapeutic methods using catalytic antibodies
03/20/1996EP0701696A1 Plasmodium vivax blood stage antigens, antibodies, and diagnostic assays
03/20/1996EP0701629A1 Bc200 rna, probes therefor and use thereof
03/20/1996EP0701628A1 Process for screening substances having a modulating effect on an interleukine-5-receptor-dependent cellular signal transmission path
03/20/1996EP0701627A1 Nucleic acid analogue assay procedures
03/20/1996EP0701624A1 Method for the determination of salmonella
03/20/1996EP0701621A1 Phytoremediation of metals
03/20/1996EP0701620A1 Virus resistant plants
03/20/1996EP0701619A1 Process for generating male sterile plants
03/20/1996EP0701618A1 Method of improving the quality of stored potatoes
03/20/1996EP0701617A1 Dna sequences and plasmids for the preparation of sugar beet with changed sucrose concentration
03/20/1996EP0701616A1 Multicistronic expression of recombinant genes in bacterial cells
03/20/1996EP0701615A1 Mutant polypeptide of protein kinase c, nucleic acid sequences coding for said polypeptide and use thereof
03/20/1996EP0701614A1 Putrescine n-methyltransferase, recombinant dna molecules encoding putrescine n-methyltransferase, and transgenic tobacco plants with decreased alkaloid content
03/20/1996EP0701613A1 Isolation of mushroom-inducing genes and their use in dna-mediated transformation of edible basidiomycetes
03/20/1996EP0701612A1 IMMUNOGENIC FORMULATION OF OspC ANTIGEN VACCINES FOR THE PREVENTION AND TREATMENT OF LYME DISEASE AND RECOMBINANT METHODS FOR THE PREPARATION OF SUCH ANTIGENS
03/20/1996EP0701611A1 Human metabotropic glutamate receptors, nucleic acids encoding same and uses thereof
03/20/1996EP0701610A1 Dna coding for the human thyrotropin-releasing hormone receptor
03/20/1996EP0701609A1 Inhibition of proliferation of vascular smooth muscle cell
03/20/1996EP0701608A1 Embryonic stem cells for making chimeric and transgenic ungulates
03/20/1996EP0701607A1 Mammals lacking expression of cd28 transgenic
03/20/1996EP0701606A1 Method of enhancing thrombolysis
03/20/1996EP0701605A1 Improved enzymes and detergents containing them
03/20/1996EP0701604A1 Immortalization of denditric cells with v-myc oncogene
03/20/1996EP0701573A1 Genetically engineered immunoglobulins
03/20/1996EP0701570A1 Thermoresistant alpha-1-antitrypsin mutein
1 ... 3714 3715 3716 3717 3718 3719 3720 3721 3722 3723 3724 3725 3726 3727 3728 3729 3730 3731 3732 3733 3734 ... 4023